Komura Kazumasa 小村和正

… Alternative Names

Komua Kazumasa 小村和正

Less

Researcher Number	10789853
Other IDs
Affiliation (Current)	2023: 大阪医科薬科大学, 医学部, 講師
Affiliation (based on the past Project Information) *help	2021 – 2023: 大阪医科薬科大学, 医学部, 講師 2019 – 2020: 大阪医科大学, 医学部, 講師 2017 – 2018: 大阪医科大学, 医学部, 助教
Review Section/Research Field	Principal Investigator Basic Section 56030:Urology-related / Urology Except Principal Investigator Basic Section 56030:Urology-related / Basic Section 55020:Digestive surgery-related / Basic Section 58010:Medical management and medical sociology-related
Keywords	Principal Investigator DNAダメージ / 腫瘍合成致死 / 耐性 / がん / 化学放射線療法 / 泌尿生殖器腫瘍 / 泌尿器がん / 膀胱がん / 膀胱癌 Except Principal Investigator 膵癌 … More / BNCT / BOAI / 浸潤癌 / 膀胱温存 / 精巣腫瘍 / microRNA / ワールブルグ効果 / PTBP1 / がんサバイバーシップ / がん疫学 / ライフコース / がん対策 / サバイバーシップ / BNN / 免疫療法 / CD4Tcell / T細胞 / マウス / BBN / NAD＋ / 免疫賦活 / 膀胱癌 / BCG / NAD+ / 癌移植 / 膵臓癌 / ゼブラフィッシュ Less

Development of synthetic lethal approach for chemo-radiation resistant tumorPrincipal Investigator
- Principal Investigator
  
  小村和正
- Project Period (FY)
  2021 – 2025
- Research Category
  
  Grant-in-Aid for Scientific Research (B)
- Review Section
  
  Basic Section 56030:Urology-related
- Research Institution
  Osaka Medical and Pharmaceutical University
がんサバイバーのライフコース疫学研究：人生のアウトカムに対する要因分析
- Principal Investigator
  
  伊藤ゆり
- Project Period (FY)
  2021 – 2024
- Research Category
  
  Grant-in-Aid for Scientific Research (B)
- Review Section
  
  Basic Section 58010:Medical management and medical sociology-related
- Research Institution
  Osaka Medical and Pharmaceutical University
PTBP1を標的にしたmicroRNAによる癌特異的エネルギー代謝機構の解明
- Principal Investigator
  
  内山和久
- Project Period (FY)
  2021 – 2023
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Review Section
  
  Basic Section 55020:Digestive surgery-related
- Research Institution
  Osaka Medical and Pharmaceutical University
Therapeutic effect of boron neutron supplementation therapy with PDL1 antibody for advanced bladder cancer (including metastasis)
- Principal Investigator
  
  東治人
- Project Period (FY)
  2021 – 2025
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Review Section
  
  Basic Section 56030:Urology-related
- Research Institution
  Osaka Medical and Pharmaceutical University
がん細胞ゼブラフィッシュ移植モデルによるアッセイ系の構築～膵癌克服への布石～
- Principal Investigator
  
  朝隈光弘
- Project Period (FY)
  2019 – 2022
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Review Section
  
  Basic Section 55020:Digestive surgery-related
- Research Institution
  Osaka Medical and Pharmaceutical University
Studies on a novel immunotherapy for bladder cancer by NAD+
- Principal Investigator
  
  上原博史
- Project Period (FY)
  2019 – 2023
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Review Section
  
  Basic Section 56030:Urology-related
- Research Institution
  Osaka Medical and Pharmaceutical University
Development of Novel Therapeutic Approach Exploiting Constitutive DNA Damage in Genitourinary CancerPrincipal Investigator
- Principal Investigator
  
  Komura Kazumasa
- Project Period (FY)
  2019 – 2021
- Research Category
  
  Grant-in-Aid for Early-Career Scientists
- Review Section
  
  Basic Section 56030:Urology-related
- Research Institution
  Osaka Medical and Pharmaceutical University
Exploring the mechanism by which BUB1 confers malignant potential in utothelial carcinomaPrincipal Investigator
- Principal Investigator
  
  Komua Kazumasa
- Project Period (FY)
  2017 – 2018
- Research Category
  
  Grant-in-Aid for Young Scientists (B)
- Research Field
  
  Urology
- Research Institution
  Osaka Medical College

All 2022 2021 2020 2019 2018 2017

All Journal Article Presentation

[Journal Article] Effectiveness of pembrolizumab in patients with urothelial carcinoma receiving proton pump inhibitors2022
- Author(s)
  Fukuokaya W,Kimura T,Komura K,Uchimoto T,Nishimura K,Yanagisawa T,Kosuke Y,Kagenori I,Fumihiko I,Shunsuke U,Shoji T,Naoki K,Shoichiro T,Mukai S,Oyamad Y,Abe H,Kamoto T,Azuma H,Miki J,Egawa S.
- Journal Title
  
  Urologic Oncology: Seminars and Original Investigations
  
  Volume: 22 Issue: 7 Pages: 346.e1-346.e8
- DOI
  10.1016/j.urolonc.2022.02.020
- Peer Reviewed / Open Access / Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-21H03070
[Journal Article] Efficacy of pembrolizumab and comprehensive CD274/PD-L1 profiles in patients previously treated with chemoradiation therapy as radical treatment in bladder cancer2022
- Author(s)
  Nishimura ｋ,Nishio K, Hirosuna K,Komura K, Hayashi T,Fukuokaya W, Ura A,Uchimoto T, Nakamura K, Fukushima T,Yano Y,Takahashi N, Nakamori K, Kinoshita S,Matsunaga T, Tsutsumi T,Tsujino T,Taniguchi K,Tanaka T,Uehara H, Takahara K,Inamoto T,Hirose Y,Kimura T,Egawa S,Azuma H.
- Journal Title
  
  Journal for ImmunoTherapy of Cancer
  
  Volume: 10 Issue: 1 Pages: e003868-e003868
- DOI
  10.1136/jitc-2021-003868
- Peer Reviewed / Open Access / Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-21H03070, KAKENHI-PROJECT-21K09386
[Journal Article] Prognostic value of the fluctuation in the neutrophil?lymphocyte ratio at 6 weeks of pembrolizumab treatment is specific to the clinical response in metastatic urothelial carcinoma2022
- Author(s)
  Uchimoto T,Nakamura K,Komura K,Fukuokaya W,Yano Y,Nishimura K,Kinoshita S,Nishio K,Fukushima T, Nakamori K,Matsunaga T,Tsutsumi T,Tsujino K,Taniguchi K,Tanaka T,Uehara H,Takahara K,Inamoto T, Kimura T,Egawa S, Azuma H.
- Journal Title
  
  Urologic Oncology: Seminars and Original Investigations
  
  Volume: 22 Issue: 7 Pages: 344.e11-344.e17
- DOI
  10.1016/j.urolonc.2022.02.012
- Peer Reviewed / Open Access / Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-21H03070
[Journal Article] Increased BUB1B/BUBR1 expression contributes to aberrant DNA repair activity leading to resistance to DNA-damaging agents2021
- Author(s)
  Komura Kazumasa、Inamoto Teruo、Tsujino Takuya、Matsui Yusuke et al.
- Journal Title
  
  Oncogene
  
  Volume: 40 Issue: 43 Pages: 6210-6222
- DOI
  10.1038/s41388-021-02021-y
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-18K18151, KAKENHI-PROJECT-18H03207, KAKENHI-PROJECT-20H04282, KAKENHI-PROJECT-21K09386
[Journal Article] Early Prostate-Specific Antigen (PSA) Change at Four Weeks of the First-Line Treatment Using Abiraterone and Enzalutamide Could Predict Early/Primary Resistance in Metastatic Castration-Resistant Prostate Cancer.2021
- Author(s)
  Uchimoto T,Komura K, Fukuokaya W, Kimura T, Takahashi K, Nishimura K, Nakamori K, Fujiwara Y, Matsunaga T, Tsutsumi T, Tsujino T, Maenosono R, Yoshikawa Y, Taniguchi K, Tanaka T, Uehara H, Ibuki N, Hirano H, Nomi H, Takahara K, Inamoto T, Egawa S, Azuma H.
- Journal Title
  
  Cancers
  
  Volume: 13 Issue: 3 Pages: 2-12
- DOI
  10.3390/cancers13030526
- Peer Reviewed / Open Access / Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-16K11033, KAKENHI-PROJECT-19K18624
[Journal Article] Bladder cancer prospective cohort study on high-risk non-muscle invasive bladder cancer after photodynamic diagnosis-assisted transurethral resection of the bladder tumor (BRIGHT study).2021
- Author(s)
  Kobayashi K,Matsuyama H,Kawai T, Ikeda A,Miyake M,Nishimoto K, Matsushita Y, Komura K,Abe T, Kume H, Nishiyama H, Fujimoto K,Oyama M, Miyake H, Inoue K,Mitsui T,Kawakita M,Ohyama C, Mizokami A,Kuroiwa H.
- Journal Title
  
  International Journal of Urology
  
  Volume: online Issue: 7 Pages: 1-7
- DOI
  10.1111/iju.14854
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-21K09386
[Journal Article] Hemodialysis Initiation in Oldest-Old Patients: A Case Series.2021
- Author(s)
  Maenosono R,Matsunaga T,Yoshikawa Y,Nishimura K,Onaka H, Komura K, Uehara H,Azuma H.
- Journal Title
  
  Case Rep Nephrol Dial
  
  Volume: 11 Issue: 3 Pages: 286-91
- DOI
  10.1159/000518706
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-21K09386
[Journal Article] 単施設における院内がん登録と生体試料をレコードリンケージした臨床・疫学研究に関するシステマティックレビュー2021
- Author(s)
  片岡葵, 太田将仁, 谷口高平, 小村和正, 福井敬祐, 伊藤ゆり
- Journal Title
  
  癌と化学療法
  
  Volume: 48 Pages: 1469-1474
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-21H03174
[Journal Article] Risk Classification for Overall Survival by the Neutrophil-Lymphocyte Ratio and the Number of Metastatic Sites in Patients Treated with Pembrolizumab-A Multicenter Collaborative Study in Japan.2021
- Author(s)
  Uchimoto T,Komura K,Fukuokaya W, Kimura T,Takahashi K, Yano Y, Nishimura K Nakamori K,Fujiwara Y,Matsunaga T,Tsutsumi T,Tsujino T, Maenosono R,Yoshikawa Y,Taniguchi K,Tanaka T,Uehara H, Hirano H,Nomi H,Takahara K,Inamoto T,Egawa S, Azuma H.
- Journal Title
  
  Cancers
  
  Volume: 13(14)3554 Issue: 14 Pages: 1-10
- DOI
  10.3390/cancers13143554
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-21K09386
[Journal Article] CRISPR Screen Contributes to Novel Target Discovery in Prostate Cancer2021
- Author(s)
  Tsujino T,Komura K, Inamoto T, Azuma H.
- Journal Title
  
  International Journal of Molecular Sciences
  
  Volume: 22 Issue: 23 Pages: 12777-12777
- DOI
  10.3390/ijms222312777
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-21K09386
[Journal Article] 筋層浸潤性膀胱癌に対する新規治療戦略：膀胱温存療法のさらなる発展に向けて2021
- Author(s)
  東　治人,小村和正、上原博史、新保大樹、山本和宏、稲元輝生.
- Journal Title
  
  泌尿器外科
  
  Volume: 34（11） Pages: 1245-56
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-21K09386
[Journal Article] Adjuvant chemotherapy improves overall survival in patients with localized upper tract urothelial carcinoma harboring pathologic vascular invasion: a propensity score-matched analysis of multi-institutional cohort2020
- Author(s)
  Matsunaga T,Komura K, Hashimoto T, Muraoka R,Satake N,Tsutsumi T,Tsujino T, Yoshikawa Y, Takai T,Minami K, Taniguchi K,Tanaka T, Uehara H,Hirano H,Nomi H, Ibuki N,Takahara K, Inamoto T,Ohno Y,Azuma H.
- Journal Title
  
  World Journal of Urology
  
  Volume: 38 Issue: 12 Pages: 3183-3190
- DOI
  10.1007/s00345-020-03118-x
- Peer Reviewed / Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-19K18624
[Journal Article] Management of alpha-herpesvirus infection following kidney transplantation: Our experience (7 cases)2020
- Author(s)
  Hirofumi Uehara, Hajime Hirano, Tomohisa Matsunaga, Koichiro Minami, Kazumasa Komura, Naokazu Ibuki, Teruo Inamoto, Hayahito Nomi, Haruhito Azuma
- Journal Title
  
  Transplantation Reports
  
  Volume: Volume 5, Issue 3, September, Issue: 3 Pages: 100051-100051
- DOI
  10.1016/j.tpr.2020.100051
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-19K09702
[Journal Article] Down-Grading of Ipsilateral Hydronephrosis by Neoadjuvant Chemotherapy Correlates with Favorable Oncological Outcomes in Patients Undergoing Radical Nephroureterectomy for Ureteral Carcinoma ..2020
- Author(s)
  Miyake M,Marugami N, Fujiwara Y, Komura K,Inamoto T,Azuma H, Matsumoto H, Matsuyama H, Fujimoto K.
- Journal Title
  
  Diagnostics
  
  Volume: 10(1) Issue: 1 Pages: 10-10
- DOI
  10.3390/diagnostics10010010
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-16K11033, KAKENHI-PROJECT-19K18624
[Journal Article] Risk Stratification for the Prediction of Overall Survival Could Assists Treatment Decision Making at the Diagnosis of Castration-Resistant Prostate Cancer - a Multicenter Collaborative Study in Japan.2020
- Author(s)
  Uchimoto T,Komura K, Fukuokaya W, Kimura T, Takahashi K, Fujiwara Y,Matsunaga T, Tsutsumi T, Tsujino T, Taniguchi K, Tanaka T, Uehara H, Ibuki N, Hirano H, Nomi H, Takahara K, Inamoto T, Egawa S, Azuma H.
- Journal Title
  
  BJU Int
  
  Volume: 127 Issue: 2 Pages: 212-21
- DOI
  10.1111/bju.15187
- Peer Reviewed / Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-16K11033, KAKENHI-PROJECT-19K18624
[Journal Article] MicroRNA-143/Musashi-2/KRAS cascade contributes positively to carcinogenesis in human bladder cancer.2019
- Author(s)
  Tsujino T,Sugito N, Taniguchi K, Honda R, Komura K, Yoshikawa Y, Takai T, Minami K, Kuranaga Y, Shinohara H, Tokumaru Y, Heishima K, Inamoto T, Azuma H, Akao Y.
- Journal Title
  
  Cancer Sci.
  
  Volume: 110(7) Issue: 7 Pages: 2189-9
- DOI
  10.1111/cas.14035
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-16K11033, KAKENHI-PROJECT-18K15273, KAKENHI-PROJECT-19K18624, KAKENHI-PROJECT-17K11164
[Journal Article] A Panel of MicroRNA Signature as a Tool for Predicting Survival of Patients with Urothelial Carcinoma of the Bladder2018
- Author(s)
  Inamoto Teruo、Uehara Hirofumi、Akao Yukihiro、Ibuki Naokazu、Komura Kazumasa、Takahara Kiyoshi、Takai Tomoaki、Uchimoto Taizo、Saito Kenkichi、Tanda Naoki、Yoshikawa Yuki、Minami Koichiro、Hirano Hajime、Nomi Hayahito、Kato Ryuji、Hayashi Tetsuya、Azuma Haruhito
- Journal Title
  
  Disease Markers
  
  Volume: 2018 Pages: 1-6
- DOI
  10.1155/2018/5468672
- Peer Reviewed / Open Access / Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-15K10611, KAKENHI-PROJECT-18K16716, KAKENHI-PROJECT-17K16821
[Journal Article] Expression of lncRNA MIR222HG co-transcribed from the miR-221/222 gene promoter facilitates the development of castration-resistant prostate cancer2018
- Author(s)
  Sun Tong、Du Shin-Yi、Armenia Joshua、Qu Fangfang、Fan Jingyu、Wang Xiaodong、Fei Teng、Komura Kazumasa、Liu Shirley X.、Lee Gwo-Shu Mary、Kantoff Philip W
- Journal Title
  
  Oncogenesis
  
  Volume: 7 Issue: 3 Pages: 30-30
- DOI
  10.1038/s41389-018-0039-5
- Peer Reviewed / Open Access / Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-17K16821
[Journal Article] SRSF3, a Splicer of the PKM Gene, Regulates Cell Growth and Maintenance of Cancer-Specific Energy Metabolism in Colon Cancer Cells.2018
- Author(s)
  Kuranaga Y, Sugito N, Shinohara H, Tsujino T, Taniguchi K, Komura K, Ito Y, Soga T, Akao Y.
- Journal Title
  
  Int J Mol Sci.
  
  Volume: 19 Issue: 10 Pages: 3012-3012
- DOI
  10.3390/ijms19103012
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-18K15273, KAKENHI-PROJECT-17J02701, KAKENHI-PROJECT-17K16821
[Journal Article] hibition controls aggressive prostate tumors deficient in Y-linked histone demethylase KDM5D.2018
- Author(s)
  Komura K、Yoshikawa Y, Shimamura T, Chakraborty G, Gerke TA, Hinohara K, Chadalavada K, Jeong SH, Armenia J, Du SY, Mazzu YZ, Taniguchi K, Ibuki N, Meyer CA, Nanjangud GJ, Inamoto T, Lee GM, Mucci LA, Azuma H, Sweeney CJ, Kantoff PW.
- Journal Title
  
  Journal of Clinical Investigation
  
  Volume: 128(7) Issue: 7 Pages: 2979-95
- DOI
  10.1172/jci96769
- Peer Reviewed / Open Access / Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-16K11033, KAKENHI-PROJECT-18K16716, KAKENHI-PUBLICLY-18H04798, KAKENHI-PROJECT-15H05325, KAKENHI-PROJECT-17K16821
[Journal Article] Preoperative Measurement of the Modified Glasgow Prognostic Score Predicts Patient Survival in Non-Metastatic Renal Cell Carcinoma Prior to Nephrectomy.2017
- Author(s)
  Tsujino T,Komura K, Matsunaga T, Yoshikawa Y, Takai T, Uchimoto T, Saito K, Tanda N, Oide R, Minami K, Uehara H, Jeong SH, Taniguchi K, Hirano H, Nomi H, Ibuki N, Takahara K, Inamoto T, Azuma H.
- Journal Title
  
  Ann Surg Oncol.
  
  Volume: 24(9) Issue: 9 Pages: 2787-93
- DOI
  10.1245/s10434-017-5948-6
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-16K11033, KAKENHI-PROJECT-17K16821
[Journal Article] The systemic inflammation-based Glasgow Prognostic Score as a powerful prognostic factor in patients with upper tract urothelial carcinoma.2017
- Author(s)
  Inamoto T,Matsuyama H, Sakano S, Ibuki N, Takahara K, Komura K, Takai T, Tsujino T, Yoshikawa Y, Minami K, Nagao K, Inoue R, Azuma H.
- Journal Title
  
  Oncotarget
  
  Volume: 8(68) Issue: 68 Pages: 113248-57
- DOI
  10.18632/oncotarget.22641
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-16K11033, KAKENHI-PROJECT-16K11034, KAKENHI-PROJECT-17K16821
[Journal Article] The combination of preoperative platelet count and neutrophil lymphocyte ratio as a prognostic indicator in localized renal cell carcinoma.2017
- Author(s)
  Takuya Tsujino,Kazumasa Komura, Atsushi Ichihashi, Takeshi Tsutsumi,Tomohisa Matsunaga, Yuki Yoshikawa, Ryoichi Maenosono, Kyohei Okita,Tomoaki Takai, Rintaro Oide, Koichiro Minami, Hirofumi Uehara, Kohei Taniguchi, Hajime Hirano, Hayahito Nomi, Naokazu Ibuki, Kiyoshi Takahara,Teruo Inamoto, Haruhito Azuma.
- Journal Title
  
  Oncotarget
  
  Volume: 8 Issue: 66 Pages: 110311-25
- DOI
  10.18632/oncotarget.22688
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-16K11033, KAKENHI-PROJECT-17K16821
[Presentation] Therapeutic Utility of ATM Inhibitor to Chemoradiation-Resistant Urothelial Carcinoma with Aberrant BUBR1 Expression.2021
- Author(s)
  Kazumasa　Komura.
- Organizer
  第80回　日本癌学会学術総会
- Data Source
  KAKENHI-PROJECT-21H03070
[Presentation] 生体腎移植前のドナー検査において腫瘍性病変が指摘され、根治的治療が可能であった3症例2020
- Author(s)
  上原博史,堤岳之,小村和正,伊夫貴直和,稲元輝生,能見勇人,東治人.
- Organizer
  第53回日本臨床腎移植学会
- Data Source
  KAKENHI-PROJECT-19K09702
[Presentation] 当施設における腎細胞癌に対するpresurgical therapyの臨床的検討2020
- Author(s)
  上原博史、伊夫貴直和、岡部知太、木村孝平、高倉一平、寺本昌司、西村一希、堤岳之、小村和正、平野一、稲元輝生、能見勇人、東治人
- Organizer
  第108回日本泌尿器科学会総会
- Data Source
  KAKENHI-PROJECT-19K09702
[Presentation] BU1B/BUBR1異常発現によるMutagenic NHEJとintact ATMの意義2020
- Author(s)
  小村和正,稲元輝生,東治人.
- Organizer
  第79回日本癌学会学術総会
- Data Source
  KAKENHI-PROJECT-19K18624
[Presentation] 放射線化学療法耐性尿路上皮がんにおけるError-Prone DNA Repairの異常亢進と臨床への意義.2019
- Author(s)
  小村和正、稲元輝生、東　治人。
- Organizer
  第78回日本癌学会学術総会
- Data Source
  KAKENHI-PROJECT-19K18624
[Presentation] 転移性腎細胞癌における2nd line Axitinibの治療効果.2019
- Author(s)
  上原博史、伊夫貴直和、藤原裕也、加納陽祐、小林大介、堤岳之、児島彬、小村和正、平野一、稲元輝生、能見勇人、東治人.
- Organizer
  第57回日本癌治療学会学術集会
- Data Source
  KAKENHI-PROJECT-19K09702
[Presentation] Aberrant Error-Prone DNA Damage Repair as a Potential Therapeutic Target in Advanced Urothelial Carcinoma2019
- Author(s)
  Komura K,Inamoto T, Uehara H, Ibuki , Minami K, Tsujino T, Azuma H.
- Organizer
  the 34rd Annual European Association of Urology (EAU) Congress 2019
- Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-17K16821
[Presentation] 2型損傷腎を抗凝固・抗血小板薬内服患者に移植し生着を得た献腎移植症例2019
- Author(s)
  上原博史,平野一,岡部知太,木村孝平,寺昌司,高倉一平,西村一希,木下将宏,徳永雄希,中森啓太,小林大介,堤岳之,小村和正,伊夫貴直和,稲元輝生,能見勇人,東治人.
- Organizer
  第55回日本移植学会総会
- Data Source
  KAKENHI-PROJECT-19K09702
[Presentation] 放射線化学療法耐性尿路上皮がんにおけるError-Prone DNA Repairの異常亢進と臨床への治療応用2019
- Author(s)
  小村　和正
- Organizer
  日本泌尿器科学会総会
- Data Source
  KAKENHI-PROJECT-17K16821
[Presentation] combination of platelet count and neutrophil to lymphocyte ratio (COP-NLR) for prediction of treatment outcome for patients with localized renal cell carcinoma.2018
- Author(s)
  Kazumasa Komura,Takuya Tsujino,Naokazu Ibuki,Teruo Inamoto,Haruhito Azuma.
- Organizer
  2018 Genitourinary Cancers Symposium
- Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-17K16821
[Presentation] Aggressive prostate cancer by the loss of male specific histone demethylase ‘KDM5D’.2018
- Author(s)
  Komura K,Inamoto T, Ibuki N, Sweeney C, Azuma H, Kantoff P.
- Organizer
  EAU 2018
- Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-17K16821
[Presentation] Decreased Expression of Male Specific Histone Demethylase “KDM5D” is Prognostic for Development of Castration-Resistant Prostate Cancer.2017
- Author(s)
  Kazumasa Komura,Seong Ho Jeong, Kunihiko Hinohara, Gwo-Shu Mary Lee, Christopher J. Sweeney, Haruhito Azuma, and Philip W. Kantoff。
- Organizer
  AUA 2017 Annual Meeting
- Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-17K16821
[Presentation] 限局性前立腺癌の高密度焦点式超音波療法でのPSA Flareの意義の検討.2017
- Author(s)
  小村　和正,伊夫貴　直和、稲元　輝生、東　治人.
- Organizer
  第31回日本泌尿器内視鏡学会総会
- Data Source
  KAKENHI-PROJECT-17K16821

1. 谷口高平 (70779686)

# of Collaborated Projects: 4 results

# of Collaborated Products: 3 results
2. 東治人 (40231914)

# of Collaborated Projects: 3 results

# of Collaborated Products: 21 results
3. 上原博史 (20822555)

# of Collaborated Projects: 2 results

# of Collaborated Products: 8 results
4. 朝隈光弘 (40559390)

# of Collaborated Projects: 1 results

# of Collaborated Products: 0 results
5. 廣瀬善信 (20293574)

# of Collaborated Projects: 1 results

# of Collaborated Products: 0 results
6. 小野富三人 (70743996)

# of Collaborated Projects: 1 results

# of Collaborated Products: 0 results
7. 辻川和丈 (10207376)

# of Collaborated Projects: 1 results

# of Collaborated Products: 0 results
8. 吉見昭秀 (80609016)

# of Collaborated Projects: 1 results

# of Collaborated Products: 0 results
9. 松井佑介 (90761495)

# of Collaborated Projects: 1 results

# of Collaborated Products: 1 results
10. 伊藤ゆり (60585305)

# of Collaborated Projects: 1 results

# of Collaborated Products: 1 results
11. 澤田典絵 (00446551)

# of Collaborated Projects: 1 results

# of Collaborated Products: 0 results
12. 東尚弘 (10402851)

# of Collaborated Projects: 1 results

# of Collaborated Products: 0 results
13. 藤阪保仁 (50411369)

# of Collaborated Projects: 1 results

# of Collaborated Products: 0 results
14. 鈴木久美 (60226503)

# of Collaborated Projects: 1 results

# of Collaborated Products: 0 results
15. 内山和久 (80232867)

# of Collaborated Projects: 1 results

# of Collaborated Products: 0 results
16. 鈴木実 (00319724)

# of Collaborated Projects: 1 results

# of Collaborated Products: 0 results
17. 小野公二 (90122407)

# of Collaborated Projects: 1 results

# of Collaborated Products: 2 results
18. 稲元輝生 (20330087)

# of Collaborated Projects: 1 results

# of Collaborated Products: 11 results
19. 高原健

# of Collaborated Projects: 0 results

# of Collaborated Products: 1 results

Komura Kazumasa 小村 和正

Komua Kazumasa 小村 和正

Research Projects

Research Products

Co-Researchers

Development of synthetic lethal approach for chemo-radiation resistant tumorPrincipal Investigator

Principal Investigator

Project Period (FY)

Research Category

Review Section

Research Institution

がんサバイバーのライフコース疫学研究：人生のアウトカムに対する要因分析

Principal Investigator

Project Period (FY)

Research Category

Review Section

Research Institution

PTBP1を標的にしたmicroRNAによる癌特異的エネルギー代謝機構の解明

Principal Investigator

Project Period (FY)

Research Category

Review Section

Research Institution

Therapeutic effect of boron neutron supplementation therapy with PDL1 antibody for advanced bladder cancer (including metastasis)

Principal Investigator

Project Period (FY)

Research Category

Review Section

Research Institution

がん細胞ゼブラフィッシュ移植モデルによるアッセイ系の構築～膵癌克服への布石～

Principal Investigator

Project Period (FY)

Research Category

Review Section

Research Institution

Studies on a novel immunotherapy for bladder cancer by NAD+

Principal Investigator

Project Period (FY)

Research Category

Review Section

Research Institution

Development of Novel Therapeutic Approach Exploiting Constitutive DNA Damage in Genitourinary CancerPrincipal Investigator

Principal Investigator

Project Period (FY)

Research Category

Review Section

Research Institution

Exploring the mechanism by which BUB1 confers malignant potential in utothelial carcinomaPrincipal Investigator

Principal Investigator

Project Period (FY)

Research Category

Research Field

Research Institution

[Journal Article] Effectiveness of pembrolizumab in patients with urothelial carcinoma receiving proton pump inhibitors2022

Author(s)

Journal Title

DOI

Data Source

[Journal Article] Efficacy of pembrolizumab and comprehensive CD274/PD-L1 profiles in patients previously treated with chemoradiation therapy as radical treatment in bladder cancer2022

Author(s)

Journal Title

DOI

Data Source

[Journal Article] Prognostic value of the fluctuation in the neutrophil?lymphocyte ratio at 6 weeks of pembrolizumab treatment is specific to the clinical response in metastatic urothelial carcinoma2022

Author(s)

Journal Title

DOI

Data Source

[Journal Article] Increased BUB1B/BUBR1 expression contributes to aberrant DNA repair activity leading to resistance to DNA-damaging agents2021

Author(s)

Journal Title

DOI

Data Source

[Journal Article] Early Prostate-Specific Antigen (PSA) Change at Four Weeks of the First-Line Treatment Using Abiraterone and Enzalutamide Could Predict Early/Primary Resistance in Metastatic Castration-Resistant Prostate Cancer.2021

Author(s)

Journal Title

DOI

Data Source

[Journal Article] Bladder cancer prospective cohort study on high-risk non-muscle invasive bladder cancer after photodynamic diagnosis-assisted transurethral resection of the bladder tumor (BRIGHT study).2021

Author(s)

Komura Kazumasa 小村和正

Komua Kazumasa 小村和正